Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook; Robert L. Hoffman; Nichol Miller; Jonathan Almaden; John Chionis; Qin Zhang; Koleen Eisele; Chaoting Liu; Cathy Zhang; Nanni Huser; Lisa Nguyen; Cinthia Costa-Jones; Sherry Niessen; Jordan D. Carelli; John D. Lapek; Scott L. Weinrich; Ping Wei; Elizabeth A. McMillan; Elizabeth A. Wilson; Tim Sen Wang; Michele McTigue; Rose Ann Ferre; You-Ai He; Sacha Ninkovic; Douglas C. Behenna; Khanh Tran; Scott C. Sutton; Asako Nagata; Martha A. Ornelas; Susan E. Kephart; Luke R. Zehnder; Brion W. Murray; Meirong Xu; James Solowiej; Ravi Visswanathan; Britton Boras; David Looper; Nathan Lee; Jadwiga Biénkowska; Zhou Zhu; Zhengyan Kan; Ying Ding; Xinmeng Jasmine Mu; Cecilia Oderup; Shahram Salek‐Ardakani; Michael A. White; Todd VanArsdale; Stephen G. Dann

doi:10.1016/j.ccell.2021.08.009

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook(Pfizer (United States)), Robert L. Hoffman(Pfizer (United States)), Nichol Miller(Pfizer (United States)), Jonathan Almaden(Pfizer (United States)), John Chionis(Pfizer (United States)), Qin Zhang(Pfizer (United States)), Koleen Eisele(Pfizer (United States)), Chaoting Liu(Pfizer (United States)), Cathy Zhang(Pfizer (United States)), Nanni Huser(Pfizer (United States)), Lisa Nguyen(Pfizer (United States)), Cinthia Costa-Jones(Pfizer (United States)), Sherry Niessen(Pfizer (United States)), Jordan D. Carelli(Pfizer (United States)), John D. Lapek(Pfizer (United States)), Scott L. Weinrich(Pfizer (United States)), Ping Wei(Pfizer (United States)), Elizabeth A. McMillan(Pfizer (United States)), Elizabeth A. Wilson(Pfizer (United States)), Tim Sen Wang(Pfizer (United States)), Michele McTigue(Pfizer (United States)), Rose Ann Ferre(Pfizer (United States)), You-Ai He(Pfizer (United States)), Sacha Ninkovic(Pfizer (United States)), Douglas C. Behenna(Pfizer (United States)), Khanh Tran(Pfizer (United States)), Scott C. Sutton(Pfizer (United States)), Asako Nagata(Pfizer (United States)), Martha A. Ornelas(Pfizer (United States)), Susan E. Kephart(Pfizer (United States)), Luke R. Zehnder(Pfizer (United States)), Brion W. Murray(Pfizer (United States)), Meirong Xu(Pfizer (United States)), James Solowiej(Pfizer (United States)), Ravi Visswanathan(Pfizer (United States)), Britton Boras(Pfizer (United States)), David Looper(Pfizer (United States)), Nathan Lee(Pfizer (United States)), Jadwiga Biénkowska(Pfizer (United States)), Zhou Zhu(Pfizer (United States)), Zhengyan Kan(Pfizer (United States)), Ying Ding(Pfizer (United States)), Xinmeng Jasmine Mu(Pfizer (United States)), Cecilia Oderup(Pfizer (United States)), Shahram Salek‐Ardakani(Pfizer (United States)), Michael A. White(Pfizer (United States)), Todd VanArsdale(Pfizer (United States)), Stephen G. Dann(Pfizer (United States))

Cancer Cell

September 13, 2021

10.1016/j.ccell.2021.08.009

Cited by 180

Abstract

Related Papers

No related papers found

Powered by citation graph analysis